RecruitingNot ApplicableNCT05724173
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Single Neuron Population Dynamics in Human Speech Motor Cortex for a Speech Prosthesis
Sponsor
Leigh R. Hochberg, MD, PhD.
Enrollment
3 participants
Start Date
Oct 18, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria4
- Between 18 and 80 years of age.
- Participants must have a diagnosis of amyotrophic lateral sclerosis (ALS) as verified by a clinical expert in neurologic diseases.
- Participants with a diagnosis of ALS with anarthria, or severe dysarthria with decline in the preceding four months.
- Must be within a three-hour drive of the Study site and geographically stable for at least 15 months after enrollment.
Exclusion Criteria3
- Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
- Chronic oral or intravenous steroids or immunosuppressive therapy
- Other serious disease or disorder that could seriously affect ability to participate in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEBrainGate Neural Interface System
Placement of the BrainGate2 sensor(s) into the speech-related cortex
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05724173
Related Trials
Multicenter ALS Imaging Study
NCT067350143 locations
Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury
NCT064432811 location
Nomad P-KAFO Study
NCT056445221 location
Breathing With Amyotrophic Lateral Sclerosis
NCT058199311 location
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
NCT0714729612 locations